The role of tregs in glioma-mediated immunosuppression: potential target for intervention.
about
Vaccine therapies in malignant gliomaTargeting glioma stem cells: a novel framework for brain tumorsPhase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium studyPI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma.Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomasIDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survivalMass spectrometry reveals changes in MHC I antigen presentation after lentivector expression of a gene regulation system.Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activity.Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection.Is HCMV a tumor promoter?Cellular immunotherapy for high-grade glioma.Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.Advanced age negatively impacts survival in an experimental brain tumor model.Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model.The immune cell infiltrate populating meningiomas is composed of mature, antigen-experienced T and B cells.Treg infiltration in glioma: a hurdle for antiglioma immunotherapy.Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
P2860
Q26829328-A79E7A38-E023-4E61-A43E-DB1C3D5A0705Q27026818-B2AED115-F6FF-48A5-8D1F-97FC2F89EF6EQ35114460-51E30A23-1850-4689-958D-7A018C986CE5Q36086507-F882EF11-0675-45CD-977B-E21A38E8A75AQ36201411-2BCA10DC-D5AA-4DCE-AAAB-548888F6B722Q36405905-2ADC1556-971C-423C-9BE4-B2D34BCF0A5AQ36652383-8641E9C0-2179-4370-B995-3C50F4FAE575Q37520219-204E1BB0-D984-454C-AF25-751270CE0917Q37771941-2C87E268-7D96-4C03-B6B8-51180D0C5536Q37805181-EA60490E-85B2-4F39-B351-2BD27FD8542FQ37851972-E35C43FB-539F-4B33-997B-A86962DDD894Q37970682-04C6F67C-7F0F-4107-8344-5A3CBC7D9692Q38227889-DA09DE7B-EEBC-449C-B246-5DA12C44AC2AQ38753736-8A4FE576-2465-4DC1-9F97-AFF21C0451B1Q38925761-9D2048BF-E27E-4756-A244-EAF0E968733EQ42927241-913B1E35-F69A-4773-BE52-B0DF655345A3Q44315396-992E3B76-A67F-4EEE-80ED-76B77287801BQ45864012-E050837A-94FD-49EC-8BCA-CE3996DC1A6E
P2860
The role of tregs in glioma-mediated immunosuppression: potential target for intervention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of tregs in glioma-me ...... ntial target for intervention.
@en
The role of tregs in glioma-me ...... ntial target for intervention.
@nl
type
label
The role of tregs in glioma-me ...... ntial target for intervention.
@en
The role of tregs in glioma-me ...... ntial target for intervention.
@nl
prefLabel
The role of tregs in glioma-me ...... ntial target for intervention.
@en
The role of tregs in glioma-me ...... ntial target for intervention.
@nl
P2093
P2860
P1476
The role of tregs in glioma-mediated immunosuppression: potential target for intervention
@en
P2093
Amy B Heimberger
William Humphries
P2860
P304
P356
10.1016/J.NEC.2009.08.012
P50
P577
2010-01-01T00:00:00Z